Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1900 of 3173 entries
View as:

An Evaluation Of Three Dose Levels Of 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) In Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT01018641 Org: User:
Start: 01/31/10 End: 07/31/11 Due: 07/31/12

Retrospective Real World Oxbryta® Data Collection and Analysis Study

Phase: N/A Priority: Normal
NCT ID: NCT04930328 Org: User:
Start: 03/20/21 End: 02/25/22 Due: 02/25/23

Real-World Outcomes of US Talazoparib-Treated Patients With Locally Advanced or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04987931 Org: User:
Start: 08/20/21 End: 10/11/21 Due: 10/11/22

Pilot Study Of Pregabalin And Prediction Of Treatment Response In Patients With Postherpetic Neuralgia

Phase: N/A Priority: Normal
NCT ID: NCT01603394 Org: User:
Start: 10/31/12 End: 06/30/13 Due: 06/30/14

A Study To Find The Best Doses Of SU011248 (Sunitinib) And Capecitabine When These Drugs Are Administered Together

Phase: N/A Priority: Normal
NCT ID: NCT00618124 Org: User:
Start: 05/31/05 End: 07/31/08 Due: 07/31/09

A Study to Assess the Effects of Talazoparib on Cardiac Repolarization in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03042910 Org: User:
Start: 10/13/16 End: 06/22/17 Due: 06/22/18

Compare Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept

Phase: N/A Priority: Normal
NCT ID: NCT00482170 Org: User:
Start: 09/30/07 End: 09/30/09 Due: 09/30/10

A Study To Evaluate The Effect Of Food On How Tasocitinib (CP-690,550) Is Absorbed And Moves Through The Body Following Oral Administration Of Tasocitinib (CP-690,550) Tablets To Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01184001 Org: User:
Start: 09/30/10 End: 09/30/10 Due: 09/30/11

Irinotecan in Patients With Advanced Metastatic Breast Cancer Who Have Experienced Failure of an Anthracycline, a Taxane, and Capecitabine

Phase: N/A Priority: Normal
NCT ID: NCT00072852 Org: User:
Start: 11/30/03 End: 05/31/07 Due: 05/31/08

This Study is to Investigate the Effect of Etanercept in Early Versus Delayed Referral for Management of Rheumatoid Arthritis Patients.

Phase: N/A Priority: Normal
NCT ID: NCT04267614 Org: User:
Start: 11/01/18 End: 12/01/18 Due: 12/01/19

A Study To Assess The Safety Of PF-06342674 In Adults With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02038764 Org: User:
Start: 06/04/14 End: 09/13/16 Due: 09/13/17

Efficacy and Safety of IV Diclofenac (DIV075V)for Pain After Elective Orthopedic Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00507026 Org: User:
Start: 07/25/07 End: 10/14/08 Due: 10/14/09

Distribution of a Single IV Dose Of [124I]-Pf 06687234 and Pf 06687234 Assessed With PET-CT Imaging In Moderate To Severe Ulcerative Colitis and Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT03414788 Org: User:
Start: 12/07/20 End: 02/01/22 Due: 02/01/23

Diflucan Research For Infant Evaluation Of Antifungal Treatment And Prophylaxis Medication

Phase: N/A Priority: Normal
NCT ID: NCT01680458 Org: User:
Start: 11/30/12 End: 10/31/14 Due: 10/31/15

The Efficacy, Safety And Toleration Of CP-866,087 In Pre-Menopausal Women With Female Sexual Arousal Disorder.

Phase: N/A Priority: Normal
NCT ID: NCT00482664 Org: User:
Start: 07/31/07 End: 10/31/08 Due: 10/31/09

Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15

Phase: N/A Priority: Normal
NCT ID: NCT05546476 Org: User:
Start: 11/21/22 End: 04/23/25 Due: 04/23/26

A Study to Examine the Clinical Effectiveness of Tafamidis in Patients With Mixed Phenotype Hereditary Transthyretin Amyloidosis

Phase: N/A Priority: Normal
NCT ID: NCT05139680 Org: User:
Start: 03/08/23 End: 05/19/23 Due: 05/19/24

Investigation of Tolterodine, Pregabalin and a Tolterodine - Pregabalin Combination for the Treatment of Overactive Bladder

Phase: N/A Priority: Normal
NCT ID: NCT00746681 Org: User:
Start: 12/31/05 End: 11/30/06 Due: 11/30/07

A Study To Compare The Effectiveness Of Tofacitinib 11 Mg Once A Day To Tofacitinib 5 Mg Twice A Day

Phase: N/A Priority: Normal
NCT ID: NCT04267380 Org: User:
Start: 09/30/18 End: 08/31/19 Due: 08/31/20

A Study to Understand the Effects of Carbamazepine on How Vepdegestrant is Processed in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06005688 Org: User:
Start: 08/18/23 End: 11/21/23 Due: 11/21/24

A Study to Assess the Safety, Effects and Palatability of Sisunatovir in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT05712460 Org: User:
Start: 02/08/23 End: 04/28/23 Due: 04/28/24

Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML

Phase: N/A Priority: Normal
NCT ID: NCT00574873 Org: User:
Start: 02/05/08 End: 05/27/15 Due: 05/27/16

Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for Acute Treatment of Temporomandibular Disorders

Phase: N/A Priority: Normal
NCT ID: NCT05262517 Org: User:
Start: 05/05/22 End: 05/18/23 Due: 05/18/24

A Safety Study For Prevenar 13 Among Chinese Children

Phase: N/A Priority: Normal
NCT ID: NCT03656939 Org: User:
Start: 08/01/18 End: 07/31/20 Due: 07/31/21

Study of the Safety and Efficacy of SU-011,248 in Adult Patients With Advanced Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00054886 Org: User:
Start: 01/31/03 End: 08/31/04 Due: 08/31/05